JNJ Johnson & Johnson

NYSE • LIFE SCIENCES

Edit Disable Enrich Back to List

Basic Information

Symbol: JNJ
Exchange: NYSE
Sector: LIFE SCIENCES
Industry: PHARMACEUTICAL PREPARATIONS
Tier: Tier 1
Status: Active

Mention Statistics

Total Mentions: 165
Recent Mentions (7 days): 9
Average Relevance: 0.9

Top Sources

Yahoo 148

SeekingAlpha 10

Benzinga 3

CNN Business 2

Finnhub 2

Recent Mentions

Article	Source	Date	Mentions	Actions
Best Biotech Penny Stocks	Benzinga	2026-02-06 12:35	1	View Original
RBC Sees Johnson & Johnson (JNJ) Well Positioned to Manag...	Yahoo	2026-02-06 12:37	3	View Original
Is Johnson & Johnson (JNJ) Pricing Reflect Recent Healthc...	Yahoo	2026-02-06 12:37	1	View Original
Why Mid Cap Dividend Stocks Are Gaining an Edge Over Larg...	Yahoo	2026-02-06 12:37	1	View Original
Johnson & Johnson Deepens Oncology And MedTech Footprint ...	Yahoo	2026-02-05 14:08	1	View Original
Johnson & Johnson's Solid Financial Position to Mitigate ...	Yahoo	2026-02-05 14:08	1	View Original
ERLEADA And DARZALEX FASPRO Updates Shape Johnson And Joh...	Yahoo	2026-02-05 14:08	2	View Original
Morgan Stanley Upgrades Johnson & Johnson to Overweight, ...	Yahoo	2026-02-05 14:08	2	View Original
Johnson & Johnson’s Myeloma Approval And What It May Mean...	Yahoo	2026-02-05 14:08	3	View Original
Is Johnson & Johnson (JNJ) The Most Profitable Healthcare...	Yahoo	2026-02-05 14:08	3	View Original
Johnson & Johnson: Fraud Claim Dismissal Today Is Not A S...	SeekingAlpha	2026-01-30 20:36	1	View Original
FDA Multiple Myeloma Approval Gives Fresh Catalyst To Joh...	Yahoo	2026-01-30 20:37	1	View Original
Scotiabank Raises Johnson & Johnson (JNJ) Target on Stron...	Yahoo	2026-01-29 21:06	3	View Original
Top Stock Reports for Johnson & Johnson, Netflix & Arista...	Yahoo	2026-01-29 16:37	1	View Original
Johnson & Johnson Weighs Cancer Drug Pricing Pressure Aga...	Yahoo	2026-01-29 16:37	1	View Original
Should You Stay Invested in J&J Stock After Q4 Beat & Sol...	Yahoo	2026-01-29 16:37	1	View Original
Texas Instruments, Circle, Johnson & Johnson: Top Analyst...	Yahoo	2026-01-29 16:37	1	View Original
DARZALEX FASPRO®-based quadruplet regimen approved in the...	Yahoo	2026-01-29 16:37	1	View Original
J&J Targets $100B+ Sales in 2026 as Growth Accelerates in...	Yahoo	2026-01-29 16:37	1	View Original
Guggenheim Lifts Johnson & Johnson (JNJ) Outlook After So...	Yahoo	2026-01-29 16:37	3	View Original